ARROW Medical Clinic

11/08/2026

DOH: Ngayong Linggo ng Kabataan, gawin nating lifestyle ang pagiging healthy!

Detalye sa Comment Section

11/08/2026

Small habits on GLP-1 that actually move the needle 💪

Appetite drops fast — but your body still needs protein and fiber daily. Eating slowly, staying hydrated, and keeping portions small protects muscle and keeps digestion smooth when hunger isn't guiding you.

More habit stacks like this inside the GLP Diet app — link in bio.

11/08/2026

On GLP-1s, eating less makes every bite matter more. 🥦

When appetite drops, nutrient gaps sneak in fast. Fruits and veggies help close them — fiber for digestion, vitamins for the energy your body still needs.

Small plate, big impact.

11/08/2026

17/07/2026

TAG-ULAN NA NAMAN, AT KASABAY NITO AY ANG BANTA NG LEPTOSPIROSIS

Kasabay ng mga pag-ulan at pagbaha, muling pinapaalalahanan ang publiko laban sa sakit na leptospirosis.

Ayon sa mga health expert, maaaring makuha ang sakit sa paglusong sa baha na kontaminado ng ihi ng daga, lalo na kung mayroong sugat o gasgas sa balat.

BASAHIN ANG KAUGNAY NA ULAT: https://bit.ly/LeptospirosisCasesInPHClimbTo2177In1stHalfOf2026

17/07/2026

Measles can be life-threatening.

Know the symptoms.

🔴 Rash that starts on the face and spreads over the body
🔴 Fever
🔴 Red and watery eyes
🔴 Runny nose
🔴 Small white spots inside the cheeks
🔴 Cough

Seek health care if you suspect you or your child has measles.

17/07/2026

Early Signs of Diabetes 👇

17/07/2026

Semaglutide, a second-generation GLP-1 receptor agonist, was associated with significantly reduced body weight and other metabolic factors in adults with schizophrenia, prediabetes, and overweight/obesity compared with placebo, research from September of 2025 showed.

In a randomized controlled trial of patients with the three conditions who were already taking second-generation antipsychotic medication, those who also received 30 weeks of semaglutide at a dose of up to 1 mg/wk had a weight reduction of 20 lb compared with those receiving a placebo, as well as a greater reduction in blood glucose and triglycerides.

The active treatment group also showed significant improvement on a physical quality-of-life measure. Read more about the research by tapping the link. https://www.medscape.com/viewarticle/glp-1-promising-option-offset-antipsychotic-weight-gain-2025a1000ob7

12/07/2026

Young women referred for polyendocrine metabolic ovarian syndrome (PMOS) had high rates of steatotic liver disease, according to new research.

The cross-sectional study of 95 young women referred to an endocrinology clinic for evaluation of PMOS (formerly called polycystic o***y syndrome [PCOS]) also found that two commonly used noninvasive screening tools failed to identify most patients with liver fibrosis.

“There was a really high rate of steatosis in women who were referred for PMOS in our population, not just those diagnosed with PMOS,” investigator Isabella Sharifi, a medical student at the University of Miami Miller School of Medicine in Miami, told Medscape Medical News. https://mdsc.pe/4h1WUcQ

12/07/2026

Off-schedule eating disrupts intestinal circadian clocks in mice, offering clues to digestive and metabolic issues in humans. More on the study: https://mdsc.pe/4vnN34S